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Abstract
Background: Antibiotic resistance (ABR) has become a major public health challenge in most parts of the world
including Ghana and is a major threat to gain in bacterial disease control. The role of prescribers in the control of
antibiotics is identified as crucial in developing interventions to control ABR. To guide policy recommendations on
ABR, a study was carried out among prescribers to identify gaps in their knowledge of ABR and to document their
prescription practices.
Method: A cross-sectional survey was conducted among prescribers from both public and private facilities in the
Brong Ahafo Region of Ghana using both quantitative and qualitative methods in 2014.
Results: Three hundred and seventy nine prescribers participated in the quantitative study and a subset of 33
participated in in-depth interviews. Majority (50.0%) of the prescribers interviewed were nurses. Most (51.0%) of the
prescribers were located in hospitals. Knowledge of ABR was high among all the prescribers. About 80.0% percent
of all prescribers agreed that the antibiotics that are currently used could lose its efficacy in future. There is
no singular formal source of information on antibiotic resistance. The prescribers held a strong perception
that antibiotic resistance is imminent though their knowledge on various resistant bacterial strains was limited. Prescribers
attributed ABR burden to factors such as poor prescription practices and limited ABR control measures. The prescription
practices of the prescribers vary but were mostly inappropriate among the lower cadre.
Conclusion: The knowledge of ABR is high among prescribers. There is however a gap in the knowledge and perception
of optimal antibiotic prescription practices among prescribers. There is the need for a formal source of information on
ABR to support prescriber’s antibiotic prescription practices.
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Background
Antibiotic resistance (ABR) has become a major public
health challenge in most parts of the sub-Saharan Africa
including Ghana [1, 2]. Several studies have reported the
escalating prevalence of ABR to cheap and available anti-
biotics in less developed countries [3–7]. For instance
some studies carried out in Ghana in 2011 showed that
the bacterial resistance to drugs such as chlorampheni-
col [8, 9], tetracycline, ampicillin and co-trimoxazole is
high (>70%) [5].
The high burden of ABR has been an existing concern
[10, 11] that has the potential of impeding appropriate
health care [12] and reducing the success of child
survival especially in developing countries [13] where
infectious diseases are still high [14, 15], health systems
are weak [16] and where the high levels of poverty [17]
may make new efficacious antibiotics inaccessible to
many patients. If unattended to, the effects of ABR will
be similar to the consequence of chloroquine resistance
observed in the late 1990s i.e. a reversal of success made
to disease control [13, 18–20].
ABR can be associated with misuse of antibiotics as a
result of several factors including inappropriate prescrip-
tion by prescribers and misuse of antibiotics by patients
[5, 12, 21]. Inappropriate prescription of antibiotics is
found to be positively correlated with inappropriate use
of antibiotics [21]. Interventions to curtail the increasing
burden of ABR are therefore urgently needed. Many
intervention programs [22] including education for pre-
scribers and consumers (population) have been recom-
mended to help elicit the judicious and appropriate use
of antibiotics [23].
Ghana recognizes the increasing burden of ABR and is
in the process of establishing policies to prevent and
manage it. The role of prescribers is identified as crucial
in developing interventions to control ABR [24]. The
knowledge, perception, and practices of prescribers on
antibiotic use and resistance was conducted to identify
gaps to guide policy recommendations to curb ABR in
Ghana.
Method
Study design
A cross-sectional survey was conducted among pre-
scribers from both public and private facilities in the
Brong Ahafo Region of Ghana using both quantitative
and qualitative methods from January to March 2014.
Study area
Brong Ahafo Region is one of the ten regions in Ghana.
The region is made up of 27 districts and municipalities.
It is the second largest region in Ghana and spans across
a total landmass of 39,557 km2. Majority of the popula-
tion are Akans. Christianity is the most common religion
(70.8%) among the population. Illiteracy rate is high:
48.5% of persons aged 15 years and above cannot read
or write in any language and about 42.0% of children are
not in school [25]. The study area has one regional hos-
pital, 27 district/municipal hospitals, 35 health centers
and 102 Community Based Health Planning and Service
(CHPS) compounds. These health facilities are classified
into levels A, B and C. Level A is a CHPS compound,
level B is a health center and level C is a hospital. Level
C facilities serve as referral centers for the levels A and
B facilities. There are 118 Medical Doctors (MD), 387
Physician Assistants (PA), 606 general nurses and 1094
Community Health Officers (CHOs) in the region [26].
In Ghana, the training duration for community health
officers, nurses, physician assistants and medical doctors
is 2, 3, 4 and 6 years respectively.
Study approach
Quantitative approach
Sampling procedure Medical doctors, physician assis-
tants, nurses and community health officers were re-
cruited to participate in the study. In each health facility,
a list of medical doctors, physician assistants, nurses,
and community health officers was obtained. The names
of all prescribers at each health facility was written on
paper and concealed by folding. The prescribers inter-
viewed were randomly selected using a lottery method.
The prescribers whose names were selected participated
in the study. In cases where the number of prescribers
present were equal to or less than the number required,
all the prescribers were interviewed.
Quantitative data collection tool All selected respon-
dents were consented and interviewed by trained research
officers, using pretested close ended questionnaires. A two
paged tool with 38 questions was used to collect the quan-
titative data. Questions were asked to explore the know-
ledge of prescribers on rational antibiotic use. Prescribers
responses to disease symptoms and hypothetical case sce-
nario management was also used as a proxy to assess their
knowledge on antibiotic use. The data collection instru-
ments were pre-tested among the different category of
study participants (3 medical doctors, 2 physician assis-
tants, 5 nurses and 2 community health officers) whose
data were not included in the final analysis. The questions
and approach of data collection was modeled on the
WHO’s standard methodology for investigating drug use
in health facilities [27].
Qualitative approach
In-depth interviews In- depth interviews were con-
ducted among a subset of prescribers until there was no
new emerging issues. The moderator was guided by a
two paged tool with open ended questions. The in-depth
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interview tool was used to explore the perception of pre-
scribers on ABR and patient demand for antibiotics.
The interviews were conducted in English. The moder-
ator sought for the respondent’s consent to record and
take notes on all discussions and assured respondent of
confidentiality, anonymity and privacy. All recorded
interviews were transcribed verbatim. Interviews were
conducted between 1 and 2 h among the doctors and
physician assistants.
Sample size calculation The sample size was calculated
using STATA version 12 (StataCorp, College Station,
Texas 77,845 USA) It was assumed that about 70.0% of
prescribers would know about ABR. At a power of 80
and 95% confidence level, a minimum of 374 prescribers
was required to estimate the knowledge of ABR among
prescribers in the study area assuming a worst estimate
of not greater than 63.0%.
Data management Completed quantitative question-
naires were checked for completeness and consistency
prior to further data management at the Kintampo
Health Research Centre Computer Laboratory. Data was
double entered into a password-protected Microsoft
FoxPro version 9.0 database. In order to protect the
integrity of participants’ responses from interviews and
survey questionnaires, all data related to the person was
de-identified. Qualitative data was transcribed verbatim
and coded electronic data are stored in password-
protected computers. Data in hard copies, including
survey questionnaires have been kept in locked boxes/
file cabinets. Only members of the study team have
access to project data. All data is reported as anonymous
without making reference to specific individuals.
Data analysis STATA version 11 was used to analyze
data from the survey. Simple proportions have been used
to describe categorical and numerical data respectively.
The Fisher’s exact was performed to test for significant
association between knowledge level and category of
prescribers.
In the qualitative analysis, a coding list was generated
based on common themes that arose from the inter-
views. At least two research staff independently reviewed
the data, to formulate preliminary coding and to ensure
inter coder reliability and data quality. Established codes
were applied to all transcripts for final analysis. QSR
Nvivo version 10 qualitative software was used for the
qualitative data management. Transcripts were reviewed
for thematic content. The findings are presented using
quotes from interviews to illustrate the major themes.
Results
A total of three hundred and seventy nine prescribers
participated in the quantitative study and a subset of 33
participated in in-depth interviews. Majority (50.0%) of
the prescribers interviewed were nurses (Table 1). Thirteen
percent of prescribers had practiced for more than 10 years
(Table 1). Most (51.0%) of the prescribers were located in
Level C facility type (Hospitals) (Table 1).
Knowledge of ABR and use among prescribers
About 81.8% of all prescribers agreed that the antibi-
otics that are currently used may not be effective in
future. The proportion of prescribers who agreed to this
was significantly highest among doctors (96.1%) com-
pared with community health officers (CHOs) (69.0%)
p < 0.01 (Table 2a).
Nineteen percent of the prescribers agreed that antibi-
otics can be added to malaria prescriptions to make
patients recover faster. This was significantly higher
among CHOs (38.0%) compared with doctors (3.9%)
p < 0.01. Compared with CHOs, a significantly high pro-
portion of doctors agreed that the use of antibiotics
could lead to dangerous allergies which could cause
Table 1 Profile and Length of Service of prescribers (N = 379)
Variable n (%)
Sex
Male 157 (41.0)
Female 222 (59.0)
Profession/type of respondent
Doctor 51 (13.0)
Physician assistant 69 (19.0)
Nurse 188 (50.0)
Community Health Officer 71 (18.0)
Length of service
0-1 year 77 (20)
2–4 years 181 (48)
5–10 years 73 (19)
More than 10 years 48 (13)
Number of years working at present facility
0–1 year 148 (39)
2–4 years 155 (41)
5–10 years 60 (16)
More than 10 years 16 (4)
Facility type
Level A (CHPS) 42 (11)
Level B (Health centre/Clinics) 144 (38)
Level C (Hospitals) 193 (51)
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Table 2 Knowledge of ABR and antibiotic use among health professionals
Variables Doctor
(n = 51)
Physician assistant
(n = 69)
Nurse
(n = 188)
CHO
(n = 71)
Total
(N = 379)
P value
Possibility of antibiotics to stop
working in future
Agree 49 (96.1) 64 (92.8) 148 (78.7) 49 (69.0) 310 (81.8) <0.01
Disagree 2 (3.9) 5 (7.2) 39 (20.8) 18 (25.4) 64 (16.9)
Don’t know 0 (00) 0 (00) 1 (0.5) 4 (5.6) 5 (1.3)
Antibiotics are effective in bacterial
infection management
Agree 51 (100) 67 (97.1) 180 (95.7) 69 (97.2) 367 (96.9) 0.70
Disagree 0 (00) 2 (2.9) 7 (3.8) 1 (1.4) 10(2.6)
Don’t know 0 (00) 0 (00) 1 (0.5) 1 (1.4) 2 (0.5)
Antibiotics are effective in viral
infection management
Agree 0 (00) 4 (5.8) 63 (33.5) 22 (40.0) 89 (23.5) <0.01
Disagree 51 (100) 64 (92.8) 123 (65.4) 47 (66.2) 285 (75.2)
Don’t Know 0 (00) 1 (1.4) 2 (1.1) 2 (2.8) 5 (1.3)
Antibiotics are effective in protozoal
infection management
Agree 15 (29.4) 20 (29.0) 96 (51.1) 21 (29.6) 152 (40.1) <0.01
Disagree 35 (68.6) 48 (69.6) 68 (36.2) 35 (49.3) 186 (49.1)
Don’t know 1 (2.0) 1 (1.4) 24 (12.8) 15 (21.1) 41 (10.8)
Antibiotics are effective in fungal
infection management
Agree 11 (21.6) 20 (29.0) 114 (60.6) 48 (67.6) 193 (51.0) <0.01
Disagree 40 (78.4) 49 (71.0) 67 (35.7) 20 (28.2) 176 (46.4)
Don’t Know 0 (00) 0 (00) 7 (3.7) 3 (4.2) 10 (2.6)
Antibiotics are effective in managing
common cold
Agree 5 (9.8) 10 (14.5) 92 (48.9) 40 (56.3) 147 (38.8) < 0.01
Disagree 46 (90.2) 57 (82.6) 91 (48.4) 31 (43.7) 225 (59.4)
Don’t Know 0 (00) 2 (2.9) 5 (2.7) 0 (00) 7 (1.8)
Antibiotics help patients to recover
faster when added to malaria
treatment
Agree 2 (3.9) 3 (4.3) 42 (22.3) 27 (38.0) 74 (19.5) < 0.01
Disagree 49 (96.1) 66 (95.7) 136 (72.3) 37 (52.1) 288 (76.0)
Don’t know 0 (00) 0 (00) 10 (5.3) 7 (9.9) 17 (4.5)
Antibiotics should be prescribed
before lab tests are done
Agree 12 (23.5) 5 (7.2) 19 (10.1) 12 (16.9) 48 (12.7) 0.03
Disagree 38 (74.5) 64 (92.8) 166 (88.3) 56 (78.9) 324 (85.5)
Don’t know 1 (2.0) 0 (00) 3 (00) 3 (4.2) 7 (1.8)
Very expensive antibiotics can be
discontinued when patient is better
Agree 8 (15.7) 10 (14.5) 38 (20.2) 20 (28.2) 76 (20.1) 0.15
Disagree 43 (84.3) 59 (85.5) 143 (76.1) 49 (69.0) 294 (69.0)
Don’t Know 0 (00) 0 (00) 7 (3.7) 2 (2.8) 9 (2.4)
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death (p < 0.01) and disagreed that antibiotics will al-
ways be effective in the treatment of same infections in
the future, p < 0.01 (Table 2b).
Sources of knowledge about antibiotic use and resistance
The sources of information on antibiotic use and resist-
ance among the prescribers included email alerts from
platforms they subscribe to, lectures at general meetings
of professional associations, books, and GHS/FDB bulletin
or circulars (Table 3). The core of their knowledge was
acquired during their formal training as demonstrated in
the comment below:
“Aside my knowledge from school, I also learn
from the BNF- British National Formulary, it has
all the medications that we prescribe so, if you
want to check the dose, you just refer to it and
also from our standard treatment guide and also
from senior colleagues” (IDI, MD)
There were no differences in the sources of informa-
tion among the different health professionals and there
was no specific channel for obtaining information on
ABR as alluded to below.
“Yes because we don't have any official source of
information about antibiotics and when you browse
[the internet] the information is not straight forward.
If we are able to get a main source of information
about antibiotics it will be well” (IDI, PA)
Barriers to prescribers access to antibiotic related
information is limited by lack of internet facility, lack of
a uniform source of information and lack of local data
on patterns of ABR.
Perception of the burden of ABR
Generally, the prescribers perceived ABR as a very
crucial issue that needs to be addressed. Their perception
Table 2 Knowledge of ABR and antibiotic use among health professionals (Continued)
Antibiotics use might lead to
dangerous allergies which could
cause death
Agree 45 (88.8) 55 (79.7) 121 (64.4) 41 (57.7) 262 (69.1) < 0.01
Disagree 6 (11.8) 12 (17.4) 50 (26.6) 23 (32.4) 91 (24.0)
Don’t Know 0 (00) 2 (2.9) 17 (9.0) 7 (9.9) 26 (6.9)
Antibiotics will always be effective in
the treatment of same infections in
the future
Agree 1 (2.0) 12 (17.4) 57 (30.3) 23 (32.4) 93 (24.5) <0.01
Disagree 49 (96.0) 55 (79.7) 125 (66.5) 39 (54.9) 268 (70.7)
Don’t Know 1 (2.0) 2 (2.9) 6 (3.2) 9 (12.7) 18 (4.8)
ABR is due to the normal correct use
of Antibiotics
Agree 2 (3.9) 2 (2.9) 30 (16.0) 20 (28.2) 54 (14.2) <0.01
Disagree 48 (94.1) 67 (97.1) 151 (80.3) 45 (63.3) 311 (82.1)
Don’t Know 1 (2.0) 0 (00) 7 (3.7) 6 (8.5) 14 (3.7)
ABR is due to the use of Antibiotics
when not prescribed
Agree 44 (86.3) 63 (91.3) 153 (81.4) 53 (74.6) 313 (82.6) 0.03
Disagree 7 (3.7) 5 (7.2) 30 (16.0) 11 (15.6) 53 (14.0)
Don’t Know 0 (00) 1 (1.4) 5 (2.7) 7 (9.9) 13 (3.4)
Table 3 Health professionals source of information on ABR
and use
Source of information Examples
Electronic media • Mobile phone messaging e.g. Short Messaging
Service (SMS)
• Internet
• Email alerts by subscription
Prints • Bulletins for Ghana Health Service or Food and
Drugs Authority
• British National Formulary
• Text books
Meetings • Professional meetings such as annual general
meeting
• Workshops
• Lectures organized by pharmaceutical
companies
• In service training
• Peers and senior colleagues
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of ABR burden was mainly informed by its impact on
Multidrug Resistant Mycobacterium tuberculosis control
and to a less extent about the control of other infections
such as Methicillin Resistant Staphylococcus aureus. The
prescribers perceived ABR could have serious conse-
quences on mortality trends and health expenditure as
demonstrated below:
“That is the most dangerous thing that can happen to
mankind. We may move to the last limit where we
cannot get any antibiotics to treat certain diseases.
Talking about antibiotics, if you look at treatment of
TB, which is a bacterium. We are strict because it is a
combination course. If you joke and one of them
develops a resistance, the other three cannot do
anything. And to get another drug that will work like
the former one doesn’t take 1 day. It takes a period.
And the cost of it is also another thing…. So we need
to be careful with antibiotics especially if mankind
wants to live long on this earth” (IDI, PA)
Perception of causes of ABR
Prescribers perception of causes of ABR were several. Their
perceptions include antibiotic over prescription, irrational
prescription of antibiotics, patient non-compliance to med-
ications, unregulated dispensing of antibiotics leading to
over the counter purchases. During the in-depth interviews
the prescribers shared their perceptions regarding ABR
from different perspectives.
“...Most of the hospitals also don’t have machines for
culture sensitivity to actually isolate the real bacteria
that is causing the disease. So just prescribing any form
of antibiotic may increase the resistance. (IDI, PA)
“…antibiotic resistance is possible because in Ghana ..,
you can go to any drug store and buy any antibiotics
without any prescription or these days we don’t know
the source of medication that we are getting whether
they are the correct or the fake ones. The efficacy
level is questionable.” (IDI, MD)
However, health facility preventive measures such as
hand washing, use of cleaning solutions, and sterilization
were rarely mentioned by the prescribers.
Practices of antibiotic use and health worker’s rational in
selecting antibiotics
To learn about prescription practices, Upper Respiratory
Tract Infections (URTI) was presented as case scenario
to prescribers.
Most of prescribers indicated that they diagnose URTI
using the patient’s complaints and physical examination
and to a less extent laboratory confirmation of the
causative agents. URTIs are often treated presumptively
with antibiotics of varying types depending on the disease
progression or severity at presentation. In some cases,
second and third generation antibiotics are primarily used.
Not all prescribers adhere to the Ghana National Treat-
ment Guidelines in their choice of antibiotics for treating
URTI. This is illustrated by the following quotes:
“Most of the URTIs practically are viral infections
and not bacteria. However, if I establish that the
cause of the URTI is a bacteria then I give
antibiotics. As first line treatment I give amoxicillin
for the typical ones or azithromycin for the atypical
ones. But if the patient have already gone for the
first line treatment drug, then I give the second
line treatment drugs like amoxiclav and other
higher antibiotics. But for kids and toddlers I give
flucloxacillin for the start because the cause is
usually gram positive, staph [Staphyloccocus] and
strep.[Streptococcus] infection” (IDI, MD)
Prescribers rationale for their choice of antibiotics in
treating patients is also influenced other factors such as
patient’s ability to pay for the antibiotic, antibiotic avail-
ability patient drug history, allowable restrictions of anti-
biotic at the level of the facility, allowable antibiotics on
insurance protocols, feedback on recovery due to treat-
ment, patient age, medical history of the patient, and
clinician wanting to impress patient. A prescriber had
this to say:
“The number one reason is the insurance. You always
want to prescribe what the patients will get in your
facility; the second factor is affordability of the
patient, if the patient can afford some of the high
ones you can prescribe for them and the third factor
will be previous drug history, what has the patient
taken before coming to you. You don’t want to
continue on the same line. The other factor will be
patient choice, sometimes you have to agree with the
patient” (IDI, MD)
The prescribers shared different experiences on patient’s
demand for antibiotics. Prescribers do not mostly consider
patients expectations in the prescription of antibiotics.
However, patients who are able demonstrate why they
should be prescribed a particular antibiotic may receive
what they ask for. Also, patients who may have had a bad
experience with a particular antibiotic may not accept the
same the antibiotic if it is prescribed for them. Patients
who are educated demand specific antibiotics but the less
educated ones accept whatever is prescribed for them.
Prescribers also hold the perception that they know
the best drugs for the patients’ illness.
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“…. No! As a clinician no! If the patient comes to me
with an expectation, then it is my job to explain to the
patient… in certain cases it maybe what you wanted
to prescribe then it makes your work easier but if it is
not, I will take my time and educate the patient on
what I think is best for the patient” (IDI, MD)
“You will have that problem of being influenced by
patients who are educated and also the health staff
themselves on the UTI (urinary tract infections), they
will request specifically for some type of antibiotic but
for the general population, they rely on what we
prescribe for them. ” (IDI, MD)
Knowledge of health facility infection control committee
and drug or therapeutic management committees
Knowledge on the availability of an infection control
committee was assessed among the prescribers. About
47.0% (178/379) of prescribers indicated non -availability
of infection control committees in their facilities. Only
16.4% of prescribers reported of functional Drug Thera-
peutics Committee (DTC) in their facility. There was a
significant difference in prescribers knowledge of a func-
tional DTC in their facility (19.6% doctors, 20.3% PAs,
18.1% nurses and 5.6% CHOs; p < 0.01).
Discussion
Prescribers are an important group of persons in the
control of ABR. They are most likely to prevent ABR in
their practice and advice patients on ABR if they are
themselves aware of ABR. In this study, the knowledge
and perception of antibiotic resistance among pre-
scribers in the Brong Ahafo Region of Ghana was
assessed. Most cadres of prescribers interviewed were
knowledgeable about ABR. Most prescribers knew that
the antibiotics we are using today can be ineffective in
the future. There was however a significant gap in the
knowledge of antibiotic use among the health profes-
sionals especially among the lower cadre of staff. It is
important that this gap is bridged as the lack of know-
ledge of appropriate antibiotic use is likely to lead to
inappropriate antibiotic stewardship and subsequently
lead to antibiotic resistance. An intervention to im-
prove antibiotic knowledge and enhance antibiotic
stewardship especially among the lower cadre of pre-
scribers is very crucial because they form the majority
of prescribers in health facilities and are the frontline
professionals in healthcare. In Ghana, there are no
systematic programs to monitor antibiotic prescription
practices among prescribers [2] and the results of this
study will support the call for an urgent action
against ABR in Ghana [5, 28].
Several varying factors such as existing health care
systems influence antibiotic use and misuse in various
parts of the world [29, 30]. The absence of diagnostic
test at health facilities is likely to affect adherence to dis-
ease treatment protocols to prevent ABR. Almost all the
prescribers interviewed knew that antibiotics are used to
manage bacterial infections. However, though some pre-
scribers knew that common cold are mostly caused by
viral infections, they presumptively treat patients with
antibiotics. The main reason for presumptive treatment
of suspected bacterial disease is mainly due to the lack
of laboratory facilities to isolate the causative organisms
and also due to the syndromic approach in patient man-
agement at the community level. This practice is likely
to lead to over prescription of antibiotics and subse-
quently bacterial resistance to available cheap antibiotics
and poor management of other nonbacterial diseases.
Rapid diagnostic test that could differentiate between
bacterial and other infections will be important in
supporting decisions to prescribe antibiotics and to
reconsider syndromic approach to treatment at the
lower level of care [27].
Prescribers were worried about ABR and the fact that
it can be a very huge public health set back. This know-
ledge of the potential problem of ABR creates the oppor-
tunity for adequate health education among all cadres of
prescribers about ABR.
Our finding that amoxicillin is the first line presump-
tively prescribed antibiotic is similar to reports of other
studies that indicates that the first generation of penicil-
lin is mostly prescribed [31, 32]. There is increasing
evidence that a number of gram-negative organisms are
developing resistance to amoxicillin and the frequent
presumptive use of it may have a role in the emerging
resistance [33, 34].
In this study, prescribers’ prescriptions were some-
times influenced by patient’s request. This finding is
similar to that reported by Rodrigues et al. [35] and
Abera et al. [36] In their studies, patients’ influence on
prescribers to prescribe specific antibiotics was identified
as one of the main factors for excessive antibiotic
prescription. Though patient involvement in disease
management is important to enhance disease cure, it is
crucial that prescribers prescribe antibiotics based on
scientific and medical basis. Prescribers rationale for
their choice of antibiotics should therefore be explained
to patients to enhance drug compliance.
In this study, there was no knowledge of an established
ABR surveillance system where prescribers can source
for information on ABR patterns in areas where they
work. This is not surprising as Ghana has no formal
ABR surveillance system as occurs in all other countries
in the World Health Organisation (WHO) African
region. [37] It is important that a national or regional
ABR surveillance system such as European Center for
Diseases Antimicrobial Resistance Surveillance Network
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[38, 39] be established to regularly update and dissemin-
ate ABR data to all health workers through effective
platforms such as email or other electronic alerts, news
bulletins, or through memos to all health facilities.
The role of hospital infection prevention protocols are
important to prevention of bacterial resistant strains
such as Methicilin Resistant Staploccous aureus (MRSA)
[40]. In this study, the knowledge of current drug resist-
ant strains of bacteria apart from Multidrug Resistant
Mycobacterium Tuberculosis was limited. Specifically,
the knowledge of extended-spectrum beta-lactamases
producing Enterobacteriaceae was limited though there
was an outbreak in a major hospitals in Ghana [28] and
reports of other resistant bacterial stains [41, 42]. In dis-
cussing causes of drug resistance, hospital infection con-
trol was also least mentioned as potential cause of drug
resistance though the Ministry of Health of Ghana has
an established policy on infection control [40]. This is
not surprising as less than 50% of respondents knew
about their institutions infection control protocols. A
functional Drug and Therapeutic Committee (DTC) in
health facilities is important in ensuring rational drug
prescriptions. In this study, less than 20% of respon-
dents indicated that there was an existing functional
DTC [43]. There is the need to strengthen infections
control policies and DTC as institutional steps in
preventing ABR.
Conclusion
The knowledge of ABR is high among prescribers. There
is however a gap in the knowledge and perception of
optimal antibiotic prescription practices among health
professionals. There is the need for a formal source of
information of ABR to support prescriber’s antibiotic
prescription practices.
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